Dr Robert Ellis

Honorary Lecturer

School of Biomedical Sciences
Faculty of Medicine

Overview

Dr Ellis completed his MD/PhD in 2019 at the University of Queensland. His thesis investigated kidney function following nephrectomy for the management of kidney cancer. His current work includes both clinical and pre-clinical research across a number of fields related to kidney health and disease, including work on kidney cancer, chronic kidney disease, and transplantation. He is currently based at the Translational Research Institute and Princess Alexandra Hospital.

Qualifications

  • Doctor of Medicine, The University of Queensland
  • Doctor of Philosophy, The University of Queensland
  • Bachelor of Health Sciences (Honours), The University of Queensland
  • Bachelor of Science, The University of Queensland

Publications

View all Publications

Available Projects

  • This project aims to characterise protein expression in renal cell carcinoma and identify novel targets with high sensitivity and specificity for various subtypes of kidney tumours. There are many translational applications of high sensitivity and specificity molecular targets, including therapeutic, radiological and histopathological.

  • This project involves cell culture of primary cancer cells, to develop in vivo models of disease. This may allow testing of therapeutic agents, with long term translational goals to guide personalised medicine.

View all Available Projects

Publications

Journal Article

Conference Publication

Other Outputs

Grants (Administered at UQ)

Possible Research Projects

Note for students: The possible research projects listed on this page may not be comprehensive or up to date. Always feel free to contact the staff for more information, and also with your own research ideas.

  • This project aims to characterise protein expression in renal cell carcinoma and identify novel targets with high sensitivity and specificity for various subtypes of kidney tumours. There are many translational applications of high sensitivity and specificity molecular targets, including therapeutic, radiological and histopathological.

  • This project involves cell culture of primary cancer cells, to develop in vivo models of disease. This may allow testing of therapeutic agents, with long term translational goals to guide personalised medicine.